IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q1 2018 Holdings

Filed 2018-05-14 | 57 holdings | $215.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Ensign Group Inc(ENSG)ACOM29358P101$8.6M325,8974.0%
Arena Pharmaceuticals Inc(ARNAEUR)ACOM NEW040047607$8.7M220,7884.1%
Glaxosmithkline PLCASPONSORED ADR37733W105$8.9M226,5844.2%
Alnylam Pharmaceuticals Inc(ALNY)ACOM02043Q107$9.4M78,8934.4%
Avexis IncACOM05366U100$9.7M78,2014.5%
Ablynx NVASPONSORED ADR00372Y105$9.9M181,8914.6%
Aerie Pharmaceuticals Inc(AERIEUR)ACOM00771V108$11.4M210,7785.3%
Radius Health IncACOM NEW750469207$12.0M333,7385.6%
R1 RCM IncACOM749397105$13.6M1,909,8876.3%
Spdr S&P 500 ETF TR(SPY)PutATR UNIT78462F103$15.8M60,0007.3%
Quality Care Pptys IncACOM747545101$20.0M1,030,6619.3%
PreviousPage 2 of 2